An announcement made by the U.S. Department of State-President’s Emergency Plan for AIDS Relief (PEPFAR) to bring U.S.-based Gilead Sciences’ breakthrough drug lenacapavir to market in high-burden HIV countries has excited the National AIDS Commission-(NAC) saying it is a sigh of relief to most affected countries including Malawi. The PEPFAR support is expected to reach...